Cybin Inc. (HELP) Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder - Slideshow (NASDAQ:HELP) 2026-03-06

Group 1 - The company is responsible for the development of transcript-related projects [1] - It publishes thousands of quarterly earnings calls per quarter and is expanding its coverage [1]